Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers.
McCall
Anthony L
AL
D001067:Appetite Depressants / Q000627:therapeutic use*; D002186:Cannabinoids / Q000037:antagonists & inhibitors*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D050177:Overweight; D010352:Patient Dropouts; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant; D016896:Treatment Outcome; D015431:Weight Loss
D001067:Appetite Depressants; D002186:Cannabinoids; D010880:Piperidines; D010919:Placebos; D011720:Pyrazoles; D000077285:Rimonabant